- Home
- SPNT vs AGIO Comparison
SPNT vs AGIO Comparison
Compare SPNT & AGIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPNT
- AGIO
- Stock Information
- Founded
- SPNT 2011
- AGIO 2007
- Country
- SPNT Bermuda
- AGIO United States
- Employees
- SPNT N/A
- AGIO N/A
- Industry
- SPNT Property-Casualty Insurers
- AGIO Biotechnology: Pharmaceutical Preparations
- Sector
- SPNT Finance
- AGIO Health Care
- Exchange
- SPNT Nasdaq
- AGIO Nasdaq
- Market Cap
- SPNT 2.3B
- AGIO 2.0B
- IPO Year
- SPNT N/A
- AGIO 2013
- Fundamental
- Price
- SPNT $15.23
- AGIO $33.23
- Analyst Decision
- SPNT
- AGIO Buy
- Analyst Count
- SPNT 0
- AGIO 7
- Target Price
- SPNT N/A
- AGIO $56.33
- AVG Volume (30 Days)
- SPNT 808.0K
- AGIO 975.9K
- Earning Date
- SPNT 02-18-2025
- AGIO 02-13-2025
- Dividend Yield
- SPNT N/A
- AGIO N/A
- EPS Growth
- SPNT 31.47
- AGIO N/A
- EPS
- SPNT 1.60
- AGIO 11.80
- Revenue
- SPNT $2,614,600,000.00
- AGIO $32,871,000.00
- Revenue This Year
- SPNT N/A
- AGIO $33.41
- Revenue Next Year
- SPNT N/A
- AGIO $172.14
- P/E Ratio
- SPNT $9.37
- AGIO $2.78
- Revenue Growth
- SPNT N/A
- AGIO 36.79
- 52 Week Low
- SPNT $11.27
- AGIO $21.18
- 52 Week High
- SPNT $16.50
- AGIO $62.58
- Technical
- Relative Strength Index (RSI)
- SPNT 54.14
- AGIO 36.88
- Support Level
- SPNT $14.23
- AGIO $31.39
- Resistance Level
- SPNT $15.81
- AGIO $35.03
- Average True Range (ATR)
- SPNT 0.51
- AGIO 1.71
- MACD
- SPNT 0.02
- AGIO 0.54
- Stochastic Oscillator
- SPNT 50.20
- AGIO 39.91
About SPNT SiriusPoint Ltd.
SiriusPoint Ltd provides property and casualty reinsurance coverage to insurance and reinsurance companies in the United States, Canada, Bermuda, the United Kingdom, and Europe. The company operates through two operating segments: Reinsurance and Insurance & Services. The company's product portfolio consists of reinsurance contracts for property insurance including both residential and commercial properties, workers' compensation, personal automobile, businesses' general liability insurance, professional liability insurance to protect professional advisors and service providers, agriculture insurance, and mortgage insurance. The majority of the revenue is generated from its Insurance & Services segment.
About AGIO Agios Pharmaceuticals Inc.
Agios Pharmaceuticals Inc is a biopharmaceutical company with a focus on developing treatments geared towards cancer and rare genetic disorders of metabolism. The company's primary focus is to develop potentially transformative small-molecule medicines. The clinical development plan for Agios' product candidates includes a precision approach with initial study designs that allow for genetically or biomarker-defined patient populations. The company seeks the potential for proof of concept early in clinical development, along with any potential for accelerated approval.